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Ischemic preconditioning (IPC), which involves intermittent periods of ischemia followed
by reperfusion, is an effective clinical intervention that reduces the risk of myocardial
injury and confers ischemic tolerance to skeletal muscle. Repeated bouts of IPC
have been shown to stimulate long-term changes vascular function, however, it is
unclear what metabolic adaptations may occur locally in the muscle. Therefore, we
investigated 7 days of bilateral lower limb IPC (4 × 5 min) above limb occlusion pressure
(220 mmHg; n = 10), or sham (20 mmHg; n = 10), on local muscle oxidative capacity
and microvascular blood flow. Oxidative capacity was measured using near-infrared
spectroscopy (NIRS) during repeated short duration arterial occlusions (300 mmHg).
Microvascular blood flow was assessed during the recovery from submaximal isometric
plantar flexion exercises at 40 and 60% of maximal voluntary contraction (MVC).
Following the intervention period, beyond the late phase of protection (72 h), muscle
oxidative recovery kinetics were speeded by 13% (rate constant pre 2.89 ± 0.47 min−1
vs. post 3.32 ± 0.69 min−1; P < 0.05) and resting muscle oxygen consumption (mV˙O2)
was reduced by 16.4% (pre 0.39 ± 0.16%.s−1 vs. post 0.33 ± 0.14%.s−1; P < 0.05).
During exercise, changes in deoxygenated hemoglobin (HHb) from rest to steady state
were reduced at 40 and 60% MVC (16 and 12%, respectively, P < 0.05) despite similar
measures of total hemoglobin (tHb). At the cessation of exercise, the time constant
for recovery in oxygenated hemoglobin (O2Hb) was accelerated at 40 and 60% MVC
(by 33 and 43%, respectively) suggesting enhanced reoxygenation in the muscle. No
changes were reported for systemic measures of resting heart rate or blood pressure.
In conclusion, repeated bouts of IPC over 7 consecutive days increased skeletal muscle
oxidative capacity and microvascular muscle blood flow. These findings are consistent
with enhanced mitochondrial and vascular function following repeated IPC and may
be of clinical or sporting interest to enhance or offset reductions in muscle oxidative
capacity.
Keywords: NIRS, blood flow restriction, exercise, ischemia, mitochondria
Frontiers in Physiology | www.frontiersin.org 1 May 2018 | Volume 9 | Article 463
fphys-09-00463 May 8, 2018 Time: 16:49 # 2
Jeffries et al. IPC Enhances Muscle Oxidative Function
INTRODUCTION
Ischemic preconditioning (IPC), first described by Murry et al.
(1986), is a technique that intermittently occludes circulatory
blood flow, interspersed by periods of tissue reperfusion. Applied
in this way, local IPC protects the myocardium from tissue
injury following ischemic insult (Murry et al., 1986). In addition,
remote adaptations in distal tissues not directly exposed to
the ischemic stimulus have also been observed (Hausenloy and
Yellon, 2008). Since its early inception, IPC has been used
for many different purposes and can be applied acutely or
repeated across a number of days. Acute IPC has been shown
to protect organs, including the myocardium (Murry et al.,
1986), kidney (Lee and Emala, 2000), liver (Yoshizumi et al.,
1998), and skeletal muscle (Gurke et al., 2000), from the damage
caused by a subsequent prolonged ischemic event. In addition,
systemic effects of IPC have also been reported to modulate
parasympathetic nervous system activity (Enko et al., 2011).
Furthermore, an acute application of IPC has beneficial effects
on exercise performance (de Groot et al., 2010; Kido et al.,
2015; Patterson et al., 2015; Tanaka et al., 2016). Protection
conferred from an acute exposure of IPC has led investigators to
examine whether repeated application may elicit dose-dependent
protection. Indeed, repeated IPC has been shown to offer greater
protection against cardiac ischemia, in a dose-dependent manor,
in animal models (Wei et al., 2011; Yamaguchi et al., 2015). In
humans, repeated IPC has been applied across 7 consecutive days
(Jones et al., 2014), episodically across an 8-week period (Jones
et al., 2015), and twice daily application for 300 days (Meng et al.,
2012). Here clinical efficacy has been shown in patients displaying
reduced stroke recurrence (Meng et al., 2012), improved wound
healing in diabetics (Shaked et al., 2015), increased coronary flow
reserve in heart failure patients (Kono et al., 2014), reductions
in systolic and diastolic blood pressure (Madias, 2011; Jones
et al., 2014), and improved vascular health (Kimura et al., 2007;
Jones et al., 2014, 2015). However, the mechanisms by which
IPC exerts protection are not well understood. Two phases
of protection have been described were an early phase offers
immediate protection which lasts several hours, linked to the
release of mediators such a bradykinin and adenosine. A second
window of protection, the late phase, follows approximately
24 h later lasting between 48 and 72 h and is dependent on
the induction of protective proteins (Loukogeorgakis et al.,
2005).
Acute application of IPC has also been shown to improve
local skeletal muscle oxygenation during exercise (Saito et al.,
2004; Kido et al., 2015; Patterson et al., 2015; Tanaka et al.,
2016). For example, Patterson et al. (2015) demonstrated an
improved maintenance of muscle oxygenation during repeated
sprint cycling during the early phase of protection. Furthermore,
IPC enhances muscle deoxygenation dynamics during whole-
body (Kido et al., 2015) and local muscular endurance exercise
(Tanaka et al., 2016), suggestive of lower O2 extraction and/or
greater blood flow to skeletal muscle. In skeletal muscle, local
application of IPC confers ischemic tolerance to subsequent
ischemic events (Gurke et al., 2000). There is also evidence that
IPC can protect against reductions in ischemic-induced glycogen
depletion (Lintz et al., 2013), restore mitochondrial dysfunction
(Thaveau et al., 2007; Mansour et al., 2012) and remotely lower
energy metabolism during sustained ischemia (Addison et al.,
2003), thus demonstrating a range of potential mechanisms
whereby skeletal muscle function is enhanced. However, to date,
little is known about the oxidative potential of skeletal muscle
following repeated bouts of IPC.
The energetic demands of muscular work are largely
supported by oxidative metabolism. Using near-infrared
spectroscopy (NIRS), muscle oxidative capacity is reduced
in clinical patient groups where normal muscle function is
impaired, such as in motor-complete spinal cord injuries
(Erickson et al., 2013), peripheral vascular disorders (Cheatle
et al., 1991), or those with sedentary lifestyles (Brizendine
et al., 2013). In comparison, endurance trained athletes display
5-fold increases in muscle oxidative function (Brizendine et al.,
2013; Adami and Rossiter, 2017). Using NIRS alongside a
series of transient arterial occlusions has enabled non-invasive
reporting of muscle oxidative capacity with good reproducibility
when compared to gold standard techniques such as magnetic
resonance spectroscopy (MRS) (Ryan et al., 2013c) and in situ
measures of respiratory capacity via muscle biopsy analysis
(Ryan et al., 2014). Interventions that can stimulate adaptations
in skeletal muscle function, other than physical exercise, may
not only be useful for athletic populations but could improve
or sustain physical activity in clinical populations, or facilitate
recovery following brief periods of immobility. The reported
increases in vascular conductance following repeated IPC (Jones
et al., 2014), alongside demonstrable effects of acute IPC on
exercise performance and local muscle O2 dynamics (Kido
et al., 2015; Patterson et al., 2015), led us to hypothesize that
repeated bouts of IPC may stimulate a sustained enhancement
of skeletal muscle oxidative capacity and microvascular blood
flow. Therefore, we examined the effects of 7 consecutive
days of bilateral lower-limb IPC on local skeletal muscle
oxidative capacity and microvascular blood flow in healthy,
young men.
MATERIALS AND METHODS
Participants
A total of 20 adult male participants volunteered for this
study (age, 26 ± 5 years; stature, 180 ± 6 cm; body mass
80± 12 kg). The participants were all actively engaged in regular
exercise (250 ± 150 min/week) that consisted of endurance
running or where involved in team sports. They were non-
smokers and not taking any medications. Participants were
advised to maintain a normal training schedule throughout the
IPC or sham intervention but not to undertake any additional
training or to reduce their current training load. A priori
sample size was calculated using G∗Power (Version 3.1.9.3).
This was determined according to changes in the deoxygenated
hemoglobin/myoglobin (HHb) time course for recovery from
moderate-intensity exercise following acute application of IPC
[1time constant (Tc) = 4.6 s; SD = 1.7] (Kido et al., 2015).
A total of 6 participants per group were deemed sufficient to
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yield a power of 0.80 and α = 0.05. A total of 10 participants
were recruited to account for experimental mortality throughout
the duration of the trial. Ethical approval was provided by the
St. Mary’s University Ethics Committee which was conducted in
accordance with the 1964 Helsinki Declaration. All participants
provided written, informed consent before testing.
Experimental Design
Participants first visited the laboratory to provide informed
consent, conduct a maximal voluntary plantar flexion
contraction (MVC) for determination of subsequent exercise
intensities and for the purposes of allocating groups. Participants
were also familiarized with the IPC pressure and electrical
stimulation procedures used in the experimental trials. The
main experimental trial began 48–72 h later after which
participants attended the laboratory on nine occasions, across 11
consecutive days. All trials were conducted at the same time of
day to eliminate circadian variation. On the first experimental
visit, baseline measurements of muscle oxygenation were
performed, followed by a series of arterial occlusions to establish
resting muscle oxygen consumption (mV˙O2) and the rate
of recovery from a brief electrical stimulation. An exercise
protocol involving plantar flexion isometric contractions over
a range of submaximal exercise intensities was performed
on a dynamometer. Participants were ranked based on their
MVC performance during the first visit and separated into an
intervention (IPC) or sham (control) group using A-B-B-A.
Each group then visited the laboratory on 7 consecutive days to
perform an IPC or sham procedure. After the final intervention,
participants returned to the laboratory 72 h later to replicate
the tests performed on the first experimental visit. The 72-h
time period was chosen as this was outside the reported early
and late phases of protection conferred by IPC (Loukogeorgakis
et al., 2005) and therefore would reflect a sustained adaptation
to the IPC stimulus. Participants were instructed to avoid
consumption of alcohol or caffeinated products for 24 h
before, and strenuous exercise 48 h before, the baseline and
post-intervention test.
Measures of mV˙O2
Following 10 min of supine rest on a padded table with
both legs fully extended, a triangular pillow was placed under
the right thigh and support placed under the participant’s
right ankle to optimize the lower leg position perpendicular
to the floor (Figure 1). Participants were informed to not
move their limbs throughout the testing procedures. A near-
infrared spectroscopy (NIRS) optode (Portamon, Artinis medical
systems) was placed on the gastrocnemius medialis (2/3 distance
from the calcaneus and anterior fossa) and secured with an elastic
bandage (Tiger Tear, Hampshire, United Kingdom) to prevent
movement and covered with an optically dense black material
to minimize the intrusion of extraneous light. The position of
the probe was marked with indelible ink which was reapplied
at regular intervals during the intervention protocol to ensure
correct placement of the optode during the post-intervention
trial. Two square electrodes (50 × 50 mm), attached to a
neuromuscular stimulator (NeuroTrac Sports, Verity Medical
NIRS optode
Electrodes
BP cuff
FIGURE 1 | Experimental setup.
LTD, Hampshire, United Kingdom), were placed immediately
next to the NIRS optode at proximal and distal skin sites.
A rapid inflating blood pressure cuff (width: 15 cm; Hokanson
SC12D, Bellevue, WA, United States) in conjunction with a
rapid cuff inflator (E20, Hokanson, Bellevue, WA, United States)
supplied by an air compressor, was placed around the upper
thigh.
Resting mV˙O2 was assessed by rapidly inflating the blood
pressure cuff to 300 mmHg, ensuring full arterial and venous
occlusion of the lower limb for 30 s. This procedure was then
repeated after 3-min rest, with data averaged over the two
measures. Following a further 3-min rest, the main test protocol
began. To examine muscle oxidative recovery, twitch electrical
stimulation (pulse duration 250 µS) was administered at a
frequency of 6 Hz (Ryan et al., 2013a) for 15 s to increase muscle
metabolic rate. Electromyostimulation allows non-selective and
synchronous recruitment of muscle fibers in the region of interest
(Gregory and Bickel, 2005). Current intensity was gradually
increased over an initial 10 s to 60 mA for patient comfort
(Doucet et al., 2012). The chosen current intensity elicited a
twitch contraction across all individuals tested. It has previously
been noted that small differences in stimulation do not influence
measurements of mV˙O2 recovery kinetics (Ryan et al., 2013a).
Immediately following the stimulation, a series of brief arterial
occlusions (300 mmHg) were performed using the following
protocol: cuff 1–5 = 5 s ON, 5 s OFF; cuff 6–10 = 5 s ON,
10 s OFF; cuff 11–15 = 10 s ON, 20 s OFF (Ryan et al.,
2012). This protocol was used to characterize the recovery of
mV˙O2 and has been shown to be reliable and reproducible
when compared to phosphorus magnetic resonance spectroscopy
(P-MRS) indexes of skeletal muscle oxidative function (Ryan
et al., 2013c), and in situ high-resolution respirometry measures
of mitochondrial respiratory capacity via muscle biopsy analysis
(Ryan et al., 2014). The exercise/cuff protocol was performed
twice with a 5-min rest period between protocols and the
two tests were then averaged. To normalize the NIRS signal,
an ischemia/hyperemia procedure was performed as follows.
Following a brief 5-s electrical stimulation at 6 Hz, the cuff was
inflated to 300 mmHg for 5 min (or until a plateau was reached).
This represented maximal deoxygenation (0%) of the tissue under
the optode. Following release of the cuff, a peak hyperemic
response (representing 100% oxygenation) was recorded. The
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short duration stimulation helped to minimize the duration of
the ischemic cuff and avoid unnecessary discomfort. All data
were normalized within each trial to this ‘physiological’ range
to allow comparisons between individuals with differing ATT
(Van Beekvelt et al., 2001; Ryan et al., 2012). Representative
experimental data from a single individual trial is shown
(Figure 2).
Calculation of mV˙O2
A blood volume correction factor was applied to each data
point as previously described (Ryan et al., 2012) based on
the assumption that during an arterial occlusion, the area
under the probe is a closed system and therefore changes in
oxygenated hemoglobin/myoglobin (O2Hb) and deoxygenated
hemoglobin/myoglobin (HHb) should occur in a 1:1 ratio.
Briefly, a blood volume correction factor was calculated
according to Eq. 1:
β(t) =
[O2Hb(t)]
(O2Hb)+ [HHb(t)] (1)
where, β is the blood volume correction factor, t represents time,
O2Hb is the oxygenated hemoglobin/myoglobin signal and HHb
is the deoxygenated hemoglobin/myoglobin signal. The blood
volume correction factor was calculated for each data point and
then applied to the raw NIRS data for O2Hb (Eq. 2) and HHb
(Eq. 3) as below:
O2Hbc(t) = O2Hb(t)− [tHb(t)× (1− β)] (2)
HHbc(t) = HHb(t)− [tHb(t)× β] (3)
where, O2Hbc and HHbc are the corrected oxygenated and
deoxygenated hemoglobin/myoglobin signals, tHb is the relative
total hemoglobin concentration from the NIRS device, β is the
blood volume correction factor, and t is time. These values for
O2Hbc and HHbc thus represent the corrected data minus any
blood volume changes.
The mV˙O2 was calculated by the slope of change in the
corrected O2Hb and HHb during the first 3 s of an arterial
occlusion by using simple linear regression. We calculated a test–
re-test reliability of 6.7% coefficient of variation (CV) for resting
mV˙O2.
Following an electrically stimulated increase in metabolic
rate, the repeated mV˙O2 measurements were then fitted to a
monoexponential curve to derive a rate constant (k). This method
utilizes linear modeling to report changes in mV˙O2 as an index of
oxidative capacity (Hamaoka et al., 1996), according to Eq. 4:
y = End − Delta× (1− e−kt) (4)
where y is the relative mV˙O2 during arterial occlusion, End is
the mV˙O2 immediately following the cessation of the electrical
stimulation, Delta is the change in mV˙O2 from rest to end
exercise, t is time, and k is the rate constant. The recovery
of mV˙O2 to resting levels, therefore, represents the maximal
oxidative capacity of the region of interest monitored in
skeletal muscle. We calculated a test–re-test reliability for the
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FIGURE 2 | Experimental trial illustrated with muscle oxygenated hemoglobin
(O2Hb) expressed as a percentage of an ischemic normalization. Two resting
30-s occlusions were performed to establish resting mV˙O2, followed by a
15-s electrical stimulation and a series of 15 brief occlusions. This was
repeated but not shown for clarity. Finally, a 5-min ischemic normalization
procedure was performed.
k assessment of oxidative function using NIRS as 8.7% CV,
which was comparable to that reported elsewhere for the same
technique (Adami and Rossiter, 2017).
Submaximal Plantar Flexion Exercise
A total of 14 participants from the initial study (age, 26 ± 5
years; stature, 182 ± 5 cm; body mass 84 ± 12 kg) took
part in an exercise protocol to further identify changes in
local muscle metabolism and blood flow. Seven participants per
group were recruited to complete this follow-up investigation
due to availability of laboratory and the duration of the
expanded testing protocol required. Participants (IPC n = 7;
Sham n = 7) conducted a range submaximal isometric plantar
flexion exercise tasks following tests of muscle oxidative capacity.
They were seated upright on a dynamometer [Kin Com Auto
Positioning (125 AP), Chattanooga Group Inc., Hixson, TN,
United States] with the knee fully extended (0o) to ensure that
the gastrocnemius contributed significantly to plantar flexor
joint movement (Cresswell et al., 1995) and the hip joint was
extended (124 ± 4o), as assessed using a goniometer. The
foot was fixed in a neutral anatomical position, with the sole
of the foot fixed perpendicular (90o) to the tibia. The lateral
malleolus was visually aligned with the center of rotation of
the dynamometer lever arm and the foot was securely fixed to
the dynamometer foot plate with Velcro straps. All measures
for each participant were recorded for future trials. Participants
conducted a warm-up, comprising of 3 × 5-s submaximal
isometric plantar flexion contractions at 25, 50, and 75% of
perceived maximum effort, separated by 30-s rest. Maximal
voluntary plantar flexion isometric contraction (MVC) was
first established during the familiarization session to enable
determination of a range of working submaximal exercise
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intensities for pre and post exercise testing. Participants were
instructed to perform three maximal isometric plantar flexion
contractions and gradually develop force from rest to maximum
over a 3- to 5-s time period, separated by 60-s rest. The
peak plantar flexion torque associated with maximal voluntary
contraction (MVC) was then recorded. If the 3rd contraction
continued to increase, additional attempts were made until a
plateau was reached.
During experimental visits participants performed
intermittent plantar flexion contractions at 40, and 60% of
MVC. The exercise protocol involved rhythmic isometric
contractions in an equal work to rest ratio (2.5-s contraction:
2.5-s rest) for a total of 2 min. The pattern was maintained
by following a digital metronome (total of 24 contractions).
This exercise time was chosen as it elicited steady-state HHb in
pilot trials. A feedback display of the actual force output was
provided to the participants who matched it at the prescribed
intensity. Recovery between the different intensity bouts was
3 min, or until NIRS data returned to baseline. Values for HHb
and tHb were reported as the delta from baseline (30 s average
prior to test) to steady state exercise to examine the metabolic
demands of the exercise bout. The HHb signal which is regarded
as blood volume insensitive during exercise was therefore used
to indicate intramuscular oxygenation status (De Blasi et al.,
1994). Following the cessation of exercise, the time course of
recovery from exercise was modeled on O2Hb off-kinetics to
evaluate oxygen delivery and utilization (McCully et al., 1994b).
A mono-exponential (Eq. 4) was fitted to the first point greater
than 1 SD above the end exercise mean over 120 s and a Tc
calculated.
NIRS Device
The NIRS signals were obtained using a portable unit consisting
of 3 channels (Portamon, Artinis Medical Systems, Zetten,
Netherlands). The system is a two-wavelength continuous wave
system that simultaneously uses the modified Beer-Lambert law
and spatially resolved spectroscopy methods. Changes in tissue
O2Hb, HHb, and tHb were measured using the differences in
absorption characteristics of infrared light at 760 and 850 nm.
Differential path factor (DPF) of 4 was used throughout. NIRS
data was connected to a computer by Bluetooth for acquisition at
10 Hz.
IPC Protocol
For the IPC protocol, automatic inflation cuffs (14.5 cm width –
Delfi Medical Innovations, Vancouver, BC, Canada) were placed
on the proximal portion of both thighs. The inflatable cuffs were
connected to a pressure gauge and were automatically inflated
to 220 mmHg (IPC) to ensure maximum occlusion across all
participants (de Groot et al., 2010). The sham group experienced
a lower pressure (20 mmHg) using the same automatic inflation
cuffs. The protocol involved 5-min occlusion, followed by 5-min
reperfusion, which was repeated four times (lasting 40 min)
in the supine position. This procedure was repeated for 7
consecutive days. To ensure the complete occlusion of arterial
inflow to the limb, each individual had their limb occlusion
pressure (LOP) assessed using a Doppler probe (UltraTec
PD1, Ultrasound Technologies, Caldicot, United Kingdom) and
automatic inflation cuff, as previously described (Loenneke et al.,
2012). Average LOP for the IPC group was 140 ± 8 mmHg and
for the sham group 151± 17 mmHg.
ATT, Heart Rate, and Blood Pressure
Adipose tissue thickness (ATT) was measured at the site of
the NIRS optode, in duplicate, to the nearest 0.1 mm using
skinfold calipers (Harpenden, Burgess Hill, United Kingdom).
The average value of skin and subcutaneous tissue thickness
for the IPC group was 6.9 ± 2.6 mm and for the sham group
6.4 ± 2.5 mm (range of 3.8–12.4 mm). This was less than half
the distance between source and the detector (35 mm). There
was no correlation between mV˙O2 and ATT when expressed
as a percentage of the ischemic normalization (R2 = 0.19437;
P > 0.05). Blood pressure was monitored using an upper arm
blood pressure monitor (Omron i-C10, Omron Healthcare Co.,
Kyoto, Japan) at the beginning of both experimental sessions,
following 10 min of supine rest. Mean arterial pressure (MAP)
was reported based on calculations of systolic blood pressure
(SBP) and diastolic blood pressure (DBP): MAP = DBP + 0.33
(SBP − DBP). Following duplicate measures of oxidative
capacity, heart rate responses were recorded in the supine
position (Polar V800, Polar Electro OY, Kempele, Finland) for
2 min (pre-occlusion), 5 min (ischemic-normalization arterial
occlusion), and 5 min (reperfusion). The periods were selected
to obtain measurements of heart rate and heart rate variability
(HRV) during rest and in response to acute lower-limb ischemia.
The raw RR intervals were converted into beat-to-beat heart rate,
after which potential ectopy and artifact was determined by a
computer algorithm that identified all RR intervals outside the
upper and lower limits (±25%) of a 5-beat moving average. Two
time-domain measures of short-term HRV were determined:
the standard deviation of all RR intervals (SDNN) and the
square root of mean squared differences of successive normal
RR intervals (RMSSD). Data were reported in milliseconds (ms).
Conducting short-term HRV over = 2-min resting intervals has
been commonly used in the literature (Dekker et al., 1997; Levy
et al., 1998) as an indication of training adaptation or health
status. The device used to measure HRV has been validated
against ECG recordings (Giles et al., 2016). Room temperature
and lighting was controlled throughout all trials (19.7 ± 0.5◦C)
and the participants were not given any instructions relating to
their breathing patterns while measurements were taking place.
The participants did not talk, consume food or drink, nor were
they given any additional verbal or visual stimuli during the
trial.
Statistical Analysis
Data are presented as means ± SD. After checks for normality,
analysis of covariance (ANCOVA) was used to determine
the difference between resting mV˙O2 and recovery kinetics,
exercise intensity and recovery, heart rate, mean arterial
pressure, and heart rate variability measurements. There was
one independent variable with two levels (IPC vs. sham), with
the participants’ pre-test baseline data used as a covariate.
Magnitude of effects was calculated with partial eta-squared
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FIGURE 3 | Resting muscle oxygen consumption pre (black) and post (white)
for the IPC (n = 10) and sham (n = 10) groups. ∗P > 0.05.
(ηp2) according to the following criteria: 0.02, a small difference;
0.13, a moderate difference; 0.26, a large difference (Cohen,
1988). Statistical analysis was performed using SPSS 21 (IBM,
Armonk, NY, United States). Curve fitting and display of data
was performed with GraphPad Prism (GraphPad Software, La
Jolla, CA, United States). Statistical significance was set at
P < 0.05.
RESULTS
Resting Muscle Oxygen Consumption
Resting mV˙O2 was comparable at baseline between groups
(IPC 0.39 ± 0.16%.s−1, Sham 0.39 ± 0.15%.s−1; P > 0.05).
Following the 7-day IPC intervention, mV˙O2 was reduced by
16.4% (IPC 0.33 ± 0.14%.s−1) compared to no change in the
control group (Sham 0.39 ± 0.14%.s−1) [F (1,0.018) = 4.493,
P = 0.039, ηp2 = 0.21], indicating a moderate effect (Figure 3).
Muscle Oxidative Capacity
Immediately following a 15-s electrical stimulation during pre-
intervention testing, end contraction mV˙O2 was increased
relative to resting mV˙O2 in both conditions (IPC 0.39 ± 0.16
to 5.01 ± 0.92%.s−1; Sham 0.39 ± 0.15 to 4.09 ± 0.94%.s−1).
Following the 7-day intervention procedure, there were no
significant changes in end contraction mV˙O2, however, ηp2
indicated a moderate effect with a trend toward a∼13% reduction
in the IPC group (IPC pre 5.01 ± 0.92 to post 4.36 ± 0.38%.s−1)
and minimal changes in the sham group (∼1.7%) (Sham pre
4.09 ± 0.94 to post 4.01 ± 0.68%.s−1) (P > 0.05, ηp2 = 0.13).
To model the recovery from 15-s electrically stimulated muscle
contractions, the rate constant (k) for the recovery of mV˙O2
was assessed via a series of brief occlusions prior to the
intervention procedure (Baseline IPC 2.89 ± 0.47 min−1; Sham
3.18 ± 1.36 min−1). The 72 h following 7-day IPC, the rate
constant for mV˙O2 recovery was increased ∼13%, with no
change in the control group (< 3%) (IPC pre 2.89 ± 0.47
to post 3.32 ± 0.69 min−1; Sham pre 3.18 ± 1.36 to post
3.25 ± 1.50 min−1) [F(1,19) = 4.897, P = 0.041, ηp2 = 0.224],
indicating a moderate effect (Figures 4A,B). A total of 9 out
of the 10 participants in the IPC group demonstrated enhanced
oxidative capacity (IPC range: 2–50%), with minor changes in the
control group (Sham range:< 7%).
Muscle Oxygenation Responses to
Submaximal Exercise
The IPC reduced delta HHb at exercise intensities of 40% MVC
(IPC 16%; Sham 2% [F(1,13) = 8.867; P = 0.014; ηp2 = 0.470])
and 60% MVC (IPC 12%; Sham 3% [F(1,13) = 4.217; P = 0.05;
ηp
2 = 0.277]) with no change in sham (Table 1). In contrast, tHb
was not different between condition (P > 0.05) (Table 1). The
Tc for recovery following exercise was increased by∼33 and 43%
at 40 and 60% of MVC, respectively [40% MVC F(1,13) = 0.824;
P = 0.038; ηp2 = 0.46] [60% MVC F(1,13) = 6.742; P = 0.025;
ηp
2 = 0.38], with no changes in the sham group (Figure 5B).
A representative figure illustrates the shift in reoxygenation after
exercise at 40% MVC following 7-day IPC (Figure 5A).
Cardiovascular Adaptations
Mean arterial pressure (MAP) was not different between groups
(P = 0.578; ηp2 = 0.019) (Table 2). There was no difference
between IPC and sham groups for post-trial measures of 2-
min resting heart rate (P = 0.255; ηp2 = 0.085), 2-min RMSSD
(P = 0.110; ηp2 = 0.162), 2-min SDNN (P = 0.076; ηp2 = 0.195),
5-min occlusion heart rate (P = 0.531; ηp2 = 0.027), and 5-min
recovery heart rate (P = 0.867; ηp2 = 0.002) (Table 2).
DISCUSSION
This study provides the first evidence that skeletal muscle
oxidative function is enhanced following repeated IPC. We
report a number of important observations. First, repeated
bouts of bilateral lower-limb IPC across 7 consecutive days
increased skeletal muscle oxidative capacity. Second, we observed
a decrease in resting skeletal muscle metabolism. Third, there
was evidence of enhanced microvascular oxygenated blood flow
following IPC that facilitated a rapid recovery from submaximal
exercise. Finally, systemic measures of resting blood pressure,
heart rate and autonomic function did not change following
IPC. Together, these findings suggest that local adaptations,
distal to the IPC stimulus, potentiate oxidative function, and
microvascular blood flow beyond the late phase (24–72 h) of
protection, despite no apparent systemic cardiovascular changes.
Enhanced Local Skeletal Muscle
Oxidative Capacity
A ∼13% increase in skeletal muscle oxidative function was
achieved in this study, by administering four bouts of arterial
occlusion for 5 min with a time equivalent reperfusion, over a
7-day period. The participant group used for this investigation
were healthy, young (average ∼26 years), active males (average
engagement in exercise ∼4 h/week), with baseline measures of
oxidative function that support a good level of physical fitness
(∼2.89 min−1) when compared values reported elsewhere using
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TABLE 1 | Delta changes in HHb and tHb following submaximal intermittent
plantar flexion contractions at 40 and 60% of 1RM among IPC (n = 7) and sham
(n = 7) groups.
(HHb) delta (a.u.) (tHb) delta (a.u)
IPC Pre IPC Post IPC Pre IPC Post
40% MVC 26.08 ± 5.81 21.96 ± 6.49∗ 55.81 ± 8.77 54.39 ± 8.80
60% MVC 29.06 ± 7.59 25.62 ± 6.79∗ 66.01 ± 7.68 64.60 ± 13.77
Sham Pre Sham Post Sham Pre Sham Post
40% MVC 25.62 ± 11.26 26.05 ± 6.96 43.96 ± 15.84 45.97 ± 8.87
60% MVC 25.88 ± 9.92 27.76 ± 9.53 50.08 ± 16.99 51.65 ± 9.76
Values are presented as mean ± SD. HHb, deoxygenated hemoglobin; tHb, total
hemoglobin; MVC, maximal voluntary contraction; a.u., auxillary units; ∗P < 0.05
comparing pre to post.
this NIRS technique. For example, elite athletic populations
(VO2peak ∼74 ml.kg−1.min−1) exhibit faster oxidative recovery
(∼3.2 min−1) when compared to sedentary individuals (VO2peak
∼34 ml.kg−1.min−1) (∼1.7 min−1) (Brizendine et al., 2013). In
contrast, patients that share characteristics of exercise intolerance
and fatigue during low-intensity work often demonstrate a
reduction in muscle oxidative capacity. This has been described
for physical inactivity (Ryan et al., 2013b), immobilization
(Krieger et al., 1980), aging (McCully et al., 1994a; Larsen et al.,
2009, 2012), chronic disease (Southern et al., 2015), and motor
complete spinal cord injury (Levy et al., 1993; McCully et al.,
2011; Erickson et al., 2013), as well as a variety of metabolic
disorders, such as obesity (Wells et al., 2008), type 2 diabetes
(Mogensen et al., 2007), and mitochondrial myopathy (van
Beekvelt et al., 1999).
Trainable differences in oxidative function have been
described using NIRS, where following a 4-week period of
endurance training, wrist flexor muscles increased their oxidative
function by 64% (Ryan et al., 2013b). Shorter bouts of training
across 7–14 days also potentiate markers of mitochondrial
adaptation, that underlie changes oxidative potential (Egan et al.,
2013). Therefore, we have observed that repeated IPC can
stimulate adaptive changes in skeletal muscle oxidative function
that are replicate to changes initiated by exercise. Despite
the moderate shift in oxidative capacity reported, the smaller
margin for improvement in a sample population that is already
healthy and trained, alongside the well-conditioned nature of the
20
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TABLE 2 | Heart rate, heart rate variability, and mean arterial pressure (MAP)
during rest and occlusion among IPC (n = 10) and sham (n = 10) groups.
Sham Pre Sham Post IPC Pre IPC Post
2-min resting HR
(b·min−1)
62 ± 9 62 ± 9 60 ± 8 64 ± 11
2-min RMSSD (ms) 145 ± 98 96 ± 19 169 ± 133 143 ± 107
2-min SDNN (ms) 113 ± 87 62 ± 19 139 ± 136 103 ± 74
5-min occlusion HR
(b·min−1)
63 ± 8 63 ± 6 61 ± 9 63 ± 9
5-min
post-occlusion HR
(b·min−1)
61 ± 9 62 ± 7 60 ± 9 63 ± 10
MAP (mmHg) 89 ± 10 87 ± 6 89 ± 6 88 ± 6
Values are expressed as mean ± SD. HR, heart rate; RMSSD, the square root
of mean squared differences of successive normal RR intervals; SDNN, standard
deviation of the normal RR intervals; MAP, mean arterial pressure.
locomotive muscle groups examined, when compared to greater
changes reported for relatively untrained wrist flexor muscles
(Ryan et al., 2013b), should be noted. We would speculate that
the potential for improvement in muscle oxidative capacity in
the lower limbs could be much greater and more easily achieved
in a sedentary or reduced mobility patient population and, thus
clinically significant where exercise programs are not appropriate.
While there has been limited research into the effects of repeated
IPC, cardiovascular adaptations have been described when IPC is
applied for 7 consecutive days (Jones et al., 2014), episodically
across a four (Kimura et al., 2007), and 8-week period (Jones
et al., 2015), and even twice daily application for 300 days (Meng
et al., 2012). Therefore, the importance of repeated IPC as a
simple, non-invasive clinical alternative to exercise prescription
to enhance skeletal muscle oxidative function alongside its
reported cardiovascular benefits, warrants further study.
Resting Muscle Metabolism
In addition to enhanced oxidative capacity, a corresponding
∼16% decrease in resting muscle metabolism occurred following
IPC. A similar observation has been made in porcine models,
where skeletal muscle energy demand was reduced following
preconditioning (Pang et al., 1995). We extend this to report a
sustained reduction 72 h following the final bout of IPC. This may
be explained by two potential mechanisms; either a reduction
in metabolic rate (reduced ATP requirement) or an increased
mitochondrial efficiency (increased ATP per molecule O2).
Interestingly, no change in resting mV˙O2 was reported following
4 weeks of endurance exercise training of the wrist flexor muscles
(Ryan et al., 2013b). However, in clinical populations, a decreased
resting muscle mV˙O2 has been reported in patients with chronic
heart failure (Abozguia et al., 2008) and patients with severe
peripheral arterial disease (Malagoni et al., 2010). In these cases,
chronic reductions in oxygen supply to the muscle lead to
adaptive changes in the periphery, which downregulate resting
mV˙O2. Patients with mitochondrial myopathies also present with
decreased resting mV˙O2, in this case due to diminished oxidative
function, which is compensated by increased blood flow to the
muscle (van Beekvelt et al., 1999). In contrast, patients with
reduced mobility, without impaired blood flow (i.e., multiple
sclerosis patients), have an increased resting mV˙O2 (Malagoni
et al., 2013). These peripheral adaptations occur to facilitate
oxidative function, thus sustaining physical activity in these
patients. Based on these observations, we would speculate that the
enhanced oxidative function we report may enable a reduction
in resting muscle metabolism via an increased mitochondrial
efficiency.
Increases in VEGF and NO (Kimura et al., 2007) that have
been reported following repeated IPC suggest that changes
in oxidative capacity and resting metabolic rate could be
linked to adaptations in mitochondrial function. During a bout
of arterial occlusion, local tissue hypoxia occurs downstream
of the occlusion site. Hypoxia stimulates VEGF, which has
been shown to activate Akt3, ultimately facilitating nuclear
localization of PGC-1α, the master regulator of biogenesis
(Wright et al., 2008). In this case, it could be hypoxia per
se that elicits an enhanced mitochondrial capacity, thereby
improving oxidative function, both at rest and following exercise.
An alternate explanation is that repeated bouts of ischemic
exercise, independent of systemic hypoxia, augment mRNA
content of PGC-1α, and markers of oxidative stress (Christiansen
et al., unpublished). Through generation of reactive oxygen
species (ROS) and subsequent activation of AMPK pathways,
mitochondrial function is augmented. However, it important
to note that excessive ROS production leads to oxidative
stress, which has been implicated in the pathophysiology of
cardiovascular diseases. Therefore, future work will need to
establish the pathway by which augmented oxidative function is
supported. A future consideration is the emerging role of post-
translational modifications of mitochondrial proteins involved in
oxidative phosphorylation and how hypoxic and ischemic stress
may modulate their function (Hofer and Wenz, 2014).
Vascular Adaptations Following IPC
We extended our primary hypothesis to speculate that if
we found an improvement in oxidative function following
repeated IPC, then this would translate to the exercising muscle.
Acute application of IPC improves muscular endurance as
evidenced by accelerated muscle deoxygenation kinetics (Kido
et al., 2015; Tanaka et al., 2016). NIRS has also been used to
describe the amplitude of response of HHb and tHb during
exercise. The HHb signal, which is regarded as blood volume
insensitive, is reported to reflect the balance between local
oxygen delivery and utilization, meaning it can report muscle
fractional oxygen extraction during exercise (De Blasi et al., 1993;
Grassi et al., 2003). During intermittent isometric contractions,
HHb was significantly reduced by ∼11–15% at differing exercise
intensities following IPC. There are various interpretations of this
finding such as a reduction in capillary recruitment during the
exercise bout, a change in capillary-venous heme concentration,
a reduction in muscle oxygen consumption, greater oxygen
delivery, or a combination of these factors. That tHb remained
unchanged, may suggest that oxygen delivery was increased
following IPC via a vascular or vasodilatory mechanism.
The recovery of muscle oxygenation during a non-occluded
state following exercise has also been used to evaluate oxidative
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function (Chance et al., 1992; McCully et al., 1994b). A delay
in recovery following exercise is due to both the time course
required for PCr resynthesis, provided that muscle pH remains
relatively stable, and the delivery of oxygen (Chance et al.,
1992; McCully et al., 1994b). During recovery from exercise,
the balance between oxygen supply and oxygen demand
shifts in favor of oxygen supply as bioenergetic resources are
restored (Chance et al., 1992). In patients with peripheral
vascular disease, oxygen resaturation is lengthened in the
lower limb due to an inhibition of blood flow (McCully
et al., 1994a, 1997). Therefore, the faster reoxygenation kinetics
noted in the IPC group following exercise at both intensities
(∼32–43%), may reflect first, an enhanced oxidative capacity
and, second, increased oxygen delivery via a vasodilatory
mechanism or vascular adaptation. Our data supports previous
findings where simultaneous increases endothelial–dependent
vasodilation (∼9%) and vascular conductance (∼14%) have been
described following daily exposure to IPC for 7 days (Jones
et al., 2014). Indeed, similar observations have also been made
following intermittent exposure over 4 weeks (Kimura et al.,
2007) and 8 weeks (Jones et al., 2015). The primary mechanism
that has been proposed to mediate such changes has identified
the sheer stress exerted on the blood vessels following a period
of ischemia and subsequent reperfusion, as a major stimulus for
microvascular adaptation and endothelial function due to the
subsequent increase in blood flow following reperfusion (Green
et al., 2010; Tinken et al., 2010). Interestingly, Jones et al. (2014)
also reported vasculature adaptations in remote areas that were
not directly exposed to the repeated ischemic stimuli, suggesting
that circulating factors such as VEGF or endothelial progenitor
cells (Kimura et al., 2007) may elicit both local and systemic
effects. Much work remains to be carried out to understand
the effect of IPC on local and systemic vascular and oxidative
function.
Systemic Cardiovascular Effects of IPC
Reductions in systolic and diastolic blood pressure have been
observed following repeated IPC (Madias, 2011; Jones et al.,
2014). However, we found no changes in blood pressure. There
are inconsistencies in the literature, with several studies reporting
no changes in blood pressure (Kimura et al., 2007; Madias,
2015) suggesting that more evidence is needed to understand
the systemic effects of IPC. In addition, no changes in resting
heart rate or autonomic function were noted between groups,
as indicated by measurements of HRV. This was unanticipated,
given the systemic effects of IPC on parasympathetic nervous
system activity that have been demonstrated (Enko et al., 2011).
Systemic cardiovascular protective effects of acute IPC are
temporal in nature, with an early (1–4 h) and late (24–72 h)
protective window (Yellon and Baxter, 1995). We postulate that
the testing protocol utilized, whereby observations were made
72 h following the final bout of IPC, could also have permitted
a partial decay in systemic cardiovascular and hemodynamic
markers described. In addition, the cohorts studied were healthy,
active, and already well-conditioned to exercise, which may have
reduced the potential for changes in cardiovascular function. It
would appear that the nature and time-course of the applied
stimulus may need to be examined in more detail. It may be
that systemic effects occur acutely after IPC or that repeated daily
frequency is needed for these improvements to be sustained.
Risks Associated With IPC
Prolonged ischemia and reperfusion generates local tissue
damage and can lead to endothelial injury, which may further
impede vascular blood flow (Thijssen et al., 2016). While the
implementation of IPC using a similar 7-day protocol prior to
an ischemia-reperfusion injury has been shown to be effective
in protecting against endothelial dysfunction (Luca et al., 2013),
the question remains as to what is regarded as a safe dose.
In addition, IPC has been shown to increase pro-inflammatory
markers of leukocyte activation which could be of potential risk
to cardiac patients (Zaugg and Lucchinetti, 2015). Therefore,
the long-term safety and optimal dose of IPC remains a real
consideration in clinical settings where underlying vascular
issues could be compounded. Based on current evidence, when
administered as a series of brief occlusions, little known side
effects have been reported for a single application, nor for
repeated applications up to 300 days (Meng et al., 2012). IPC
also remains an effective technique to elicit cardioprotection in
patients undergoing cardiac surgery.
Limitations
A potential confounding factor in this study was the control over
the level of exercise fitness in the individuals tested. This may
have impacted the ability to enhance skeletal muscle function
using IPC. We reported on average 4 h/week exercise that
consisted of running or team sport training. However, further
insight into the effectiveness of IPC to enhance skeletal muscle
oxidative function in athletic populations, sedentary and/or
clinical populations with reduced muscle activity, is needed.
For the IPC stimulus itself, the optimal strategy in terms of
number of repeated applications required, length of occlusion,
number of occlusions, and timings of protection to elicit these
oxidative changes, as well as safety, presents future questions
for the scientific community. In addition, the remote effects on
skeletal muscle not directly exposed to the ischemic stimuli also
warrant further study. Heterogeneity of blood flow under the
NIRS optode may also have impacted measurements of skeletal
muscle oxidative function. We attempted to minimize this by
standardizing placement of the optode and maintaining standard
laboratory conditions for all testing. NIRS signal penetration is
estimated to be one-half of the interoptode distance (in this case
35 mm), therefore, we monitored participants to ensure that
subcutaneous adipose tissue was > 15 mm to limit absorption
and scattering of light. Additional studies using multiple-source
detector probes would help further validate our findings. Finally,
the contribution of myoglobin to the NIRS signal remains
controversial, with suggestions ranging from 20% at rest to up
to 70% during exercise (Marcinek et al., 2007; Davis and Barstow,
2013). Separation of these spectra cannot be performed using the
NIRS device used in this study. Therefore, future work will need
to discriminate whether these contributions affect the measures
of oxidative function performed in this study.
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CONCLUSION
Skeletal muscle is highly adaptable to multiple physiological
stimuli. Here, repeated bouts of IPC stimulus over 7 consecutive
days increased skeletal muscle oxidative capacity, decreased
resting muscle metabolism, and enhanced microvascular
oxygenation. It is clear that the adaptations reported may have
resulted from changes in hemodynamics induced by a single
bout of IPC, activation of molecular pathways, or diffusible
factors that mediate protective effects. Repeated activation of
these mechanisms over 7 days could explain the long-term
benefits beyond the reported acute late phase of protection
following IPC (+ 72 h). Enhancement of skeletal muscle oxidative
potential, described here, has not been previously reported
following repeated IPC but may suggest a potential longer
term effect on muscle performance. Future studies will need
to address the mechanisms by which IPC enhances oxidative
function at a cellular level, although it is likely that changes
in mitochondrial function contribute to these effects. These
findings will be of particular interest to athletic and clinical
populations.
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